Kennedy Cuts Childhood Vaccine Schedule to 11 From 17, Citing Discredited Claims
Updated
Updated · Los Angeles Times · Jul 3
Kennedy Cuts Childhood Vaccine Schedule to 11 From 17, Citing Discredited Claims
3 articles · Updated · Los Angeles Times · Jul 3
Summary
HHS in January cut the recommended childhood immunization schedule to 11 vaccines from 17, dropping shots for COVID-19, hepatitis and meningitis without the usual professional consultations, according to the report.
2,134 measles cases had been recorded in the U.S. by June 25, nearing 2025’s 2,288 total as vaccination rates remain below the 95% herd-immunity threshold and Kennedy continues to question MMR safety.
The administration also made state vaccine reporting for Medicaid and CHIP voluntary rather than mandatory, a change KFF said could make it harder to track immunization declines among children.
The article places the vaccine rollback alongside broader child-health pressures, including proposed WIC fruit-and-vegetable cuts to $10 from $26 and a 1.9 million drop in children’s Medicaid and CHIP enrollment through March 2026.
With measles resurging after its elimination, what other preventable diseases might make a comeback in the United States?
Amid shifting federal health advice, how can families best safeguard their children’s future against rising health risks?
Do budget cuts to child welfare programs ultimately create larger, unforeseen costs for society in the long run?
Legal Battle Over Kennedy’s 2026 Vaccine Rollback: Court Reinstates Full Childhood Immunization Schedule Amid Public Health Alarm
Overview
In January 2026, Robert F. Kennedy Jr. and the CDC made major changes to the childhood vaccine schedule, cutting the number of recommended vaccines from 18 to 11 and removing protections against several diseases. These changes quickly faced legal challenges from six medical organizations, leading to a pivotal court ruling in March 2026 by Judge Brian Murphy. The judge halted the new schedule, reversed the January changes, and reinstated the previous, more comprehensive vaccine recommendations. This legal battle highlights the importance of evidence-based decision-making in public health and has created ongoing uncertainty and debate about national vaccine policy.